Viewing Study NCT05713851


Ignite Creation Date: 2025-12-24 @ 11:39 PM
Ignite Modification Date: 2025-12-25 @ 9:30 PM
Study NCT ID: NCT05713851
Status: RECRUITING
Last Update Posted: 2024-03-05
First Post: 2023-01-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Dapaglifozin to Avoid Acute Kindey Injury (AKI) to Chronic Kidney Disease (CKD) Transition: DAKI-CKD Study
Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-01-01
Start Date Type: ACTUAL
Primary Completion Date: 2024-12-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-01-01
Completion Date Type: ESTIMATED
First Submit Date: 2023-01-26
First Submit QC Date: None
Study First Post Date: 2023-02-06
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-03-04
Last Update Post Date: 2024-03-05
Last Update Post Date Type: ACTUAL